Baxter International Inc. (LON:0QK8)
London
· Delayed Price · Currency is GBP · Price in USD | Market Cap | 10.88B |
| Revenue (ttm) | 8.34B |
| Net Income (ttm) | -433.43M |
| Shares Out | n/a |
| EPS (ttm) | -0.85 |
| PE Ratio | n/a |
| Forward PE | 11.17 |
| Dividend | 0.62 (2.13%) |
| Ex-Dividend Date | May 30, 2025 |
| Volume | 1,805 |
| Average Volume | 1,871 |
| Open | 29.45 |
| Previous Close | 30.07 |
| Day's Range | 28.55 - 29.45 |
| 52-Week Range | 26.44 - 40.31 |
| Beta | n/a |
| RSI | 35.01 |
| Earnings Date | Jul 31, 2025 |
About Baxter International
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; administrative sets; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technolog... [Read more]
News
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2212289210-ecb882996249447fb55b294b486bff46.jpg)
Medical Equipment Maker Baxter International Names New CEO
Baxter International on Monday named Andrew Hider, chief executive of Canadian automation solutions firm ATS Corp., its new CEO. Shares of both companies fell.
Baxter International Names ATS Hider as Next Chief Executive Officer
Baxter appoints Andrew Hider as CEO
Baxter International Names Andrew Hider as CEO
Baxter International said on Monday that Andrew Hider will take over as the medical device maker's new Chief Executive Officer.
Baxter Appoints Andrew Hider Chief Executive Officer
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the appointment of Andrew Hider as president and chief executive officer (CEO), and a m...
Baxter Publishes Annual Corporate Responsibility Report, Demonstrating Ongoing Action to Make a Meaningful Difference Around the World
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today published its 2024 Corporate Responsibility Report. The annual report demonstrates Baxter's commi...
Mountain Heating and Cooling Transforms Historic Baxter Hotel with Innovative Mitsubishi Heat Pump Installation
Bozeman, June 11, 2025 (GLOBE NEWSWIRE) -- Bozeman, Montana - Mountain Heating and Cooling recently shared details about their Mitsubishi Heat Pump Installation at the Historic Baxter Hotel in Bozeman...
BAXTER TO Present at Goldman Sachs 46th Annual Global Healthcare Conference 2025
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 on Tuesday, June 10, 20...
Skinner helps Exeter defeat second-string Saints but Baxter issues warning
Exeter 42-14 Northampton ‘We have a lot to work on,’ admits Chiefs director Sometimes there is just one acceptable outcome and, from Exeter’s perspective, this victory was the absolute minimum require...
The 'Goldilocks' Case For Baxter International
Explore Baxter International's potential turnaround as a divestiture boosts its balance sheet. Discover if years of double-digit returns await.
Baxter Declares Quarterly Dividend
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share o...
Baxter International Inc. 2025 Q1 - Results - Earnings Call Presentation
The following slide deck was published by Baxter International Inc.
Baxter International Inc. (BAX) Q1 2025 Earnings Call Transcript
Baxter Reports Strong Medical Devices Sales In Q1, Lifts 2025 Guidance, Stock Jumps
On Thursday, Baxter International Inc. (NYSE: BAX) reported a first-quarter 2025 adjusted EPS of 62 cents, beating the management guidance of 47 to 50 cents and the Wall Street estimate of 48 cents ....
Baxter Reports Strong Medical Devices Sales In Q1, Lifts 2025 Guidance, Stock Jumps
On Thursday, Baxter International Inc. BAX reported a first-quarter 2025 adjusted EPS of 62 cents, beating the management guidance of 47 to 50 cents and the Wall Street estimate of 48 cents.
Baxter stock rises on earnings beat, guidance raise
Baxter International (NYSE:BAX) surpasses Q1 earnings estimates and raises profit guidance, driven by 11% U.S. sales growth. Read more here.
Baxter tops quarterly estimates on strong demand for medical devices
Medical products maker Baxter International on Thursday beat Wall Street estimates for first-quarter revenue and profit, helped by the robust demand for its intravenous (IV) solutions and patient-moni...
Baxter Non-GAAP EPS of $0.55 beats by $0.07, revenue of $2.63B beats by $40M
Baxter Reports First-Quarter 2025 Results
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the first quarter of 2025. “Our solid performance in the first quarter of 20...
Baxter Q1 2025 Earnings Preview
Baxter to Present at Bank of America Securities 2025 Health Care Conference
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Bank of America Securities 2025 Health Care Conference on Tuesday, May 13, 2025. Jo...
A total of 12 of the 30 Dow stocks will announce earnings this week.
This week no fewer than 12 of the Dow 30 stocks will be announcing earnings this week including Coca Cola, Visa and Mastercard, Caterpillar, Apple and Amazon. . Below is the complete list, days and ti...
Baxter: Messy, Yet Appealing, If New Management Can Deliver
Baxter’s valuation looks fair, but high debt, pressured earnings, and a reduced dividend make the outlook murky. Check out why BAX stock is a hold.
What Does the Market Think About Baxter Intl?
Baxter Intl's (NYSE: BAX) short percent of float has risen 13.65% since its last report. The company recently reported that it has 18.16 million shares sold short , which is 5.33% of all regular shar...
Goldman's John Marshall provides stock opportunities ahead of earning season
John Marshall, Goldman Sachs head of derivatives research, joins 'Money Movers' to discuss the current market environment, individual companies Goldman looked at, and much more.